Technical Analysis for OTIC - Otonomy, Inc.

Grade Last Price % Change Price Change
grade B 2.75 -4.84% -0.14
OTIC closed down 4.84 percent on Friday, March 22, 2019, on 1.48 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Up Down
See historical OTIC trend table...

Date Alert Name Type % Chg
Mar 22 200 DMA Support Bullish 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Wide Bands Range Expansion -4.84%
Mar 21 Overbought Stochastic Strength -4.84%
Mar 20 Outside Day Range Expansion -6.46%
Mar 20 Wide Bands Range Expansion -6.46%

Older signals for OTIC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Otonomy, Inc. develops and commercializes therapeutics for the treatment of ear diseases and disorders primarily in the United States. Its lead product candidate is AuriPro, a sustained-exposure antibiotic, which is in Phase III clinical trials to treat pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone that is in a Phase IIb clinical trial for the treatment of patients with Ménière's disease; and OTO-311, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in preclinical development as a potential treatment for tinnitus. Otonomy, Inc. was founded in 2008 and is headquartered in San Diego, California.
Medicine Clinical Medicine Surgery Disorders Otorhinolaryngology Tinnitus
Is OTIC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.85
52 Week Low 1.5
Average Volume 138,227
200-Day Moving Average 2.7495
50-Day Moving Average 2.258
20-Day Moving Average 2.591
10-Day Moving Average 2.821
Average True Range 0.1551
ADX 43.52
+DI 27.5343
-DI 12.0707
Chandelier Exit (Long, 3 ATRs ) 2.5547
Chandelier Exit (Short, 3 ATRs ) 2.4653
Upper Bollinger Band 3.1013
Lower Bollinger Band 2.0807
Percent B (%b) 0.66
BandWidth 39.390197
MACD Line 0.1955
MACD Signal Line 0.1833
MACD Histogram 0.0122
Fundamentals Value
Market Cap 83.33 Million
Num Shares 30.3 Million
EPS -3.45
Price-to-Earnings (P/E) Ratio -0.80
Price-to-Sales 71.13
Price-to-Book 0.61
PEG Ratio -0.05
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.10
Resistance 3 (R3) 3.12 3.02 3.04
Resistance 2 (R2) 3.02 2.94 3.01 3.02
Resistance 1 (R1) 2.89 2.88 2.84 2.87 3.00
Pivot Point 2.79 2.79 2.77 2.78 2.79
Support 1 (S1) 2.66 2.71 2.61 2.64 2.50
Support 2 (S2) 2.56 2.65 2.55 2.48
Support 3 (S3) 2.43 2.56 2.46
Support 4 (S4) 2.41